In accordance, ongoing studies from our group show that pharmacological treatment with hemin and genetic overexpression of HO-1 in HNSCC cells induces cell viability and cell cycle progression (unpublished results). Here, HMOX1 is linked to head and neck squamous cell carcinoma.